Aortic valve repair in patients with aortic regurgitation: Experience with the first 100 cases  by Holubec, Tomas et al.
Available online at www.sciencedirect.comjournal homepage: www.elsevier.com/locate/crvasa
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 7 9 – e 4 8 60010-8650/$ - see fro
http://dx.doi.org/10
☆This work was s
[00179906] and by t
nCorresponding a
E-mail addressesOriginal Research ArticleAortic valve repair in patients with aortic
regurgitation: Experience with the ﬁrst 100 cases$Tomas Holubeca,b,n, Pavel Zacekb, Martin Tunab, Jan Dominikb, Jan Harrerb,
Petr Telekesc, Pavel Nedbalc, Jan Vojacekb
aDepartment of Cardiovascular Surgery, University Hospital Zurich, Switzerland
bDepartment of Cardiac Surgery, Charles University Prague, Faculty of Medicine and University Hospital Hradec Kralove,
Czech Republic
cDepartment of Cardiology, Heart Centre, Regional Hospital Liberec, Czech Republica r t i c l e i n f o
Article history:
Received 3 June 2013
Received in revised form
27 August 2013
Accepted 11 September 2013
Available online 18 September 2013
Keywords:
Aortic regurgitation
Aortic valve repair
Aortic valve-sparing operationsnt matter & 2013 The Cze
.1016/j.crvasa.2013.09.002
upported by the project
he program [PRVOUK P37
uthor at: Department of
: tomas.holubec@usz.ch,a b s t r a c t
Introduction: The aim of this study was to analyze short- and mid-term results of aortic
valve repair.
Material and methods: One hundred consecutive patients (24 females; mean age 50.3 years,
range 23–77 years) with aortic regurgitation underwent aortic valve repair between
November 2007 and October 2012. Sixty patients had bicuspid aortic valve, and 82 patients
demonstrated aortic regurgitation greater than mild (4 grade 2). The ascending aorta/
aortic root was replaced in 67 patients. Aortic cusp repair was necessary in 74 patients and
additional aortic annulus stabilization was required in 48 cases. Follow-up ranged from 1 to
59 months (cumulative of 220 patient-years, median 25 months) and was complete
in 100%.
Results: There was no 30-day mortality and two patients died in the follow-up. The overall
4-year survival was 98% and freedom from cardiac death was 99% at 4 years. During the
follow-up eight patients underwent aortic valve-related reoperation due to progression of
aortic regurgitation and another six patients showed aortic regurgitation more than mild
(4 grade 2). In both aspects there was no statistically signiﬁcant difference between
patients without and with aortic root replacement (p¼0.402 and p¼0.650). There were no
signiﬁcant bleeding or thromboembolic events during the follow-up.
Conclusions: Short- and mid-term data analysis revealed an excellent survival and accep-
table results of aortic repair, comparable with other larger published studies. We think,
therefore, aortic valve repair should be a part of contemporary cardio-surgical armamen-
tarium, especially in younger patients with an appropriate indication.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Over the long period, aortic valve replacement by prosthesis
[1] or replacement of the aortic root by composite graft [2] has
been considered the gold standard in surgical treatment of
patients with aortic valve regurgitation and/or aortic root
dilatation. Yacoub et al. [3] presented their ﬁrst experience
with aortic root remodeling in 1983, and David and Feindel [4]
published their series of aortic valve reimplantation in 1992.
Since this time aortic valve repair has evolved and become
standardized and reproducible treatment option [5–7]. It is
therefore an important part of contemporary cardiac surgery.
The results of aortic valve-sparing operations have been
shown to be comparable to composite graft valve and root
replacement [8,9] even in the treatment of acute Type A aortic
dissection [10]. However, there is an indisputable advantage
of valve-sparing operations attributed to the elimination of
certain risks related to aortic valve replacement. The most
serious complications are thromboembolic and bleeding
events caused by anticoagulation therapy in mechanical
valve substitutes, structural deterioration of bioprostheses,
and risk of endocarditis in both. Conversely, aortic valve
repair is technically more demanding and there is a sub-
stantial risk of repair failure.
The aims of our study were: (1) to assess the short- and
mid-term results of aortic valve repair, (2) to examine the
inﬂuence of different types of aortic repair on the occurrence
of reoperation and the recurrence of aortic regurgitation (AR).Table 1 – Preoperative data.
N
Age (years) (median and range)
Female gender
Hypertension
Coronary artery disease
Type A dissection
Marfan syndrome
NYHA functional class
I
II
III
IV
Bicuspid aortic valve
LV EF (%)a
450
30–50
o30
LV end-systolic diameter (mm)a
No data
LV end-diastolic diameter (mm)a
Aortic regurgitation (grade)
0 (none/trace)
1 (trivial)
2 (mild)
3 (moderate)
4 (severe)
Maximum diameter of ascending aorta (mm)a
AV pathology without aortic root or ascending aorta aneurysm
NYHA  New York Heart Association Functional Class; LV  Left ventr
a Mean7standard deviation.2. Material and methods
2.1. Study population
One hundred consecutive patients underwent aortic valve
repair at the Department of Cardiac Surgery at University
Hospital Hradec Kralove between November 2007 and October
2012. The patient age ranged from 23 to 77 years with a mean
of 50.3713 years. Twenty-four patients were female (Table 1).
All patients were Caucasian. Vojacek et al. previously pub-
lished our early experience with aortic valve repair in this
journal [11].
Informed consent was obtained from each patient, and the
institutional review board approved the study.
2.2. Clinical data and follow-up
A prospective collection of patients' data was performed.
Before surgery, all patients were examined by transesopha-
geal echocardiography (TEE), some of them also by angiogra-
phy and computed tomography. Routinely, an intraoperative
TEE was performed to assess the immediate result of the
operation. The aortic regurgitation was classiﬁed as follows:
Grade 0 – none/trace, grade 1 – trivial, grade 2 –mild, grade 3 –
moderate and grade 4 – severe. The type of aortic valve
coaptation was classiﬁed as described by Pethig et al. [12] type
A – above, type B – at the level, and type C – below the level of
annular plane (Fig. 1).100
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icular; EF  ejection fraction; AV  aortic valve.
Fig. 1 – Illustration showing the type of aortic valve
coaptation as assessed by echocardiography. Type A (blue
line) – deepest point of the coaptation Z2 mm above the
level of the aortic annulus (or within the prosthesis). Type B
(red line) – deepest point of the coaptation at the level of the
aortic annulus (or slightly below the prosthesis). Type C
(green line) – deepest point of the coaptation Z2 mm below
the level of the aortic annulus (or Z2 mm below the
prosthesis). Adapted and modiﬁed from Pethig et al. [12].
(For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this
article.)
Fig. 2 – Illustration depicting measurement of the cusp
effective height using an aortic caliper. Effective height is the
height difference between the central free margins and the
aortic insertion lines. (STJ¼sinotubular junction; ZK¼zone
of coaptation; eH¼cusp effective height; AN¼aortic annulus
or aortoventricular junction). Adapted and modiﬁed from
Schäfers et al. [13].
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regular basis with clinical assessment and transthoracic
echocardiography (TTE). Preoperative demographic and clin-
ical characteristics are shown in Table 1.
2.3. Surgical technique
All operations were performed through a median sternotomy on
cardiopulmonary bypass with either ascending aorta, femoral, or
subclavian artery cannulation depending on the distal extension
of the aortic disease. After aortic cross-clamping, transverse
ascending aortotomy, and institution of cold blood cardioplegia,
the aortic valve was exposed and inspected. The assessment of
the aortic valve was focused on the quantity and quality of cusp
tissue (measurement of effective and geometric height of the
leaﬂet), and the presence and location of degenerative changes,
calciﬁcations and cusp fenestrations. The aortic root was
inspected for size and the quality of aortic wall tissue.
Over the time, we have used different surgical techniques
to treat aortic cusp pathology. Initially, we performed a free
margin resuspension with running polytetraﬂuoroethylene
(PTFE) suture. In the majority of aortic valve repair we havebeen applying a simple central plication of the free edge of
cusps with the resuspension of the effective height of the
leaﬂet up to 8–10mm to treat any residual or induced prolapse
(Fig. 2) [13]. In patients with bicuspid aortic valve with calciﬁed
raphe we performed a triangular resection of the fused cusps,
either with primary suture or with a pericardial patch.
In the majority of cases, additionally, the ascending aorta
and/or aortic root were replaced, using either the root
remodeling technique as described by Yacoub et al. [3], aortic
valve reimplantation according to David and Feindel [4] or
supracoronary replacement of ascending aorta. If aortic
annulus was dilated, it was then addressed by either sub-
comissural plication as published by Cabrol et al. [14], by
placement of PTFE annuloplasty suture according to Schäfers
et al. [15] or by implantation of an external aortic annulo-
plasty ring as described by Lansac et al. [16].2.4. Statistical analysis
Valve-related outcomes were deﬁned per published guidelines
[17]. Continuous variables were reported as means7standard
deviation with/without ranges and were compared using a
paired t-test. Categorical variables were reported using the
number and percentage of observations. The probability of
freedom from events was calculated according to the Kaplan–
Meier method. Freedom-from-events curves were compared by
log-rank test. A p-value o0.05 was considered to indicate
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the IBMs SPSSs Statistics software program (version 21.0.0.0 for
MS Windows, IBM Corporation, Armonk, NY, USA).3. Results
3.1. Surgical procedure
The operative clinical data are shown in Table 2. In 33
patients an isolated aortic valve repair was performed and
aortic cusp repair was necessary in 74 patients. Aortic valve-
sparing root replacement was performed in 41 patients (11
David procedure and 30 Yacoub procedures). Supracoron-
ary replacement of ascending aorta without root replacement
was performed in 26 patients and aortic hemi-/arch replace-
ment in eight patients. Additional aortic annulus stabilization
was required in 48 cases. The Extra-Aortic annuloplasty ring
(Coronéo Inc., Canada) was used in 25 patients, always in
combination with aortic root remodeling. In the remaining 23
patients who underwent isolated aortic valve repair the aortic
annulus was reduced and stabilized using subcomissural
plication or preferably PTFE annuloplasty suture (Table 2).Table 2 – Operative data.
N 100
Isolated aortic valve repair 33
Aortic cusp repair 74
David procedure 11
Yacoub procedure 30
Additional annulus stabilization 48
Subcomissural plication 9 (19%)
PTFE annuloplasty suture 14 (29%)
External aortic annuloplasty 25 (52%)
Ascending aorta replacement 67
Aortic hemi-/arch replacement 8
Concomitant surgery
Mitral valve repair 9
Tricuspid valve repair 2
MAZE procedure 6
CABG 5
CPB time (min)a 123768
Cross-clamp time (min)a 96748
Circulatory arrest time (min)ab 22717
Post-CPB aortic regurgitation (grade)
0–1 97
41 2
No data 1
Post-CPB aortic valve mean gradient (mmHg)a 1177
No data 11
Post-CPB type of aortic cusp coaptation
A 85
B 13
C 0
No data 2
PTFE – polytetraﬂuoroethylene; CABG  coronary artery bypass
grafting; CPB  cardio-pulmonary bypass.
a Mean7standard deviation.
b In ﬁve patients.3.2. Clinical data
The TEE performed after termination of CPB in the operating
room showed ARr1 in 97% of patients, the mean gradient
1177 mmHg and the type of coaptation “A” in 85% of patients
(Table 2).
The postoperative clinical data are shown in Table 3.
There was no 30-day mortality. The median length of stay
in the intensive care unit was 2 days and the median hospital
stay was 11 days. Reoperation for bleeding and/or tamponade
was necessary in three patients. Three patients suffered from
periprocedural stroke of ischemic etiology. One patient
underwent aortic and hemiarch replacement under circula-
tory arrest with antegrade cerebral perfusion. He developed a
major stroke with a permanent impairment and died 1.5
months after the procedure as a consequence of this neuro-
logical insult. Two other patients suffered from minor stroke
with complete regression of the symptoms at discharge.
There was one patient with multiorgan failure, who recov-
ered successfully without consequences. The pre-discharge
TTE showed ARr1 in 93% of patients (Table 3).
3.3. Follow-up and late clinical outcome
Clinical follow-up was complete for 100% of patients; a
cumulative follow-up of 220 patient-years with a median of
25 (range: 1–59) months (Table 4). The overall 4-year survival
was 9872% (Fig. 3). Two patients died during the follow-up.
One of them died from a non-cardiac etiology 15 months after
David procedure due to a pancreatitis following kidney
transplantation. The other patient died 1.5 month after
Yacoub procedure due to consequences of major periopera-
tive stroke.
During follow-up, eight patients underwent aortic valve
reoperation due to progression of AR, ﬁve of them had
bicuspid aortic valve. Reasons for reoperation were as fol-
lows: cusp prolapse (n¼4), dilation of annulus (n¼3), cusp
retraction (n¼2), tearing of central plicating stitches (n¼1),
and tearing of cleft/raphe suture (n¼1). In 7/8 patients aortic
valve was replaced with a prosthesis. In one patient aortic
valve was re-repaired. All eight patients recovered easily fromTable 3 – Postoperative data.
N 100
ICU length of stay (days) (median and range) 2 (131)
Hospital length of stay (days) (median and range) 11 (841)
Reexploration for bleeding or tamponadea 4
Blood loss (ml/24 h)b 5087439
Reintubation 0
Stroke 3
Multiorgan failure 1
Deep sternal wound infection 0
Discharge aortic regurgitation (grade)
0–1 93
41 4
42 0
No data 3
30-day mortality 0
a In three patients.
b Mean7standard deviation.
Table 4 – Follow-up data.
N 100
Follow-up completness 100%
Follow-up (months) (median and range) 25 (159)
Follow-up (patient-years) 220
Death 2
Reoperation due to recurrent aortic regurgitation 8
NYHA functional class
I 74 (82%)
II 16 (18%)
4II 0
LV EF (%)a 6178
450 82 (91%)
30–50 7 (8%)
o30 1 (1%)
AV mean gradient (mmHg)a 974
No data 4 (4%)
LV end-diastolic diameter (mm)a 5376
No data 3 (3%)
Aortic regurgitation (grade)
0 (none/trace) 36 (40%)
1 (trivial) 32 (36%)
2 (mild) 15 (17%)
3 (moderate) 3 (3%)
4 (severe) 4 (4%)
Aortic cusp coaptation
A 75 (83%)
B 13 (15%)
C 1 (1%)
No data 1 (1%)
NYHA  New York Heart Association Functional Class; LV  Left
ventricular; EF  ejection fraction; AV  aortic valve.
a Mean7standard deviation.
Fig. 3 – Kaplan–Meier curve showing overall survival of
patients after aortic valve repair. (pts¼patients). Fig. 4 – (A) Kaplan–Meier curve showing overall freedom
from aortic valve-related reoperation in patients after aortic
valve repair. (B) Kaplan–Meier curves showing freedom from
aortic valve-related reoperation in patients after aortic valve
repair without (solid line) and with root replacement
(dashed line). (pts¼patients; AV¼aortic valve).
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patients came back with infective prosthetic valve endocar-
ditis and both underwent the second reoperation. In one ofthem, the aortic root was replaced with cryopreserved aortic
homograft and second patient underwent the Bentall proce-
dure with mechanical conduit. Both patients recovered well
and are alive without the signs of recurrent infection.
The overall 3-year freedom from aortic valve-related
reoperation was 8874% (Fig. 4A). The 3-year freedom from
aortic valve-related reoperation was 8875% for repair with-
out root replacement and 9078% for repair with root replace-
ment, respectively (p¼0.402) (Fig. 4B). Additionally, there was
no incidence of bleeding or thromboembolic events during
the follow-up.
At the latest follow-up, NYHA functional class was avail-
able in all alive and non-reoperated patients. Seventy-four
patients (82%) are in NYHA I, 16 patients (18%) are in NYHA II.
There are no patients with NYHA4II (Table 4).
Echocardiographic follow-up was complete in 100% of
patients. The TTE data at latest follow-up of all alive and
non-reoperated patients are shown in Table 4. Eighty-three
patients (93%) have ARr2, and six patients (7%) have AR42.
The overall 3-year freedom from AR42 was 8375% for the
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AR42 was 8576% for repair without root replacement and
80710% for repair with root replacement, respectively
(p¼0.650) (Fig. 5B). The mean gradient over aortic valve was
974 mmHg and the type of coaptation of aortic valve was
graded as “A” in 83% of patients. The mean left ventricular
end-diastolic diameter was 5376 mm, showing a statistically
signiﬁcant reduction (p¼0.000) comparing to preoperative
value. Left ventricular ejection fraction (EF)450% was found
in 91% of the patients.4. Discussion
Similar to mitral valve repair, which has been clearly shown
to be superior to mitral valve replacement [18], a successful
and durable aortic valve repair represents an attractive
surgical option especially for younger patients with AR.
However, replacement of regurgitant aortic valve or aortic
root with mechanical prostheses, xenografts or conduits
(Bentall procedure) are still considered as the procedure ofFig. 5 – (A) Kaplan–Meier curve showing overall freedom
from aortic regurgitation of grade more than two in patients
after aortic valve repair. (B) Kaplan–Meier curves showing
freedom from aortic regurgitation of grade more than two in
patients after aortic valve repair without (solid line) and with
root replacement (dashed line). (pts¼patients; AR¼aortic
regurgitation).choice in many cardiac centers, particularly in case of
regurgitant bicuspid aortic valve. One of the main reasons
of this low penetration of aortic valve sparing techniques
among aortic valve surgery is the inability to assess the
mechanism of aortic regurgitation systematically, and to
apply appropriate, reproducible, and standardized techniques
of aortic valve repair [19,20].
During the past 5 years aortic valve repair has been
implemented at our department, while operating on 100
consecutive patients presenting with AR. We found excellent
short-term and very acceptable mid-term results, with no
30-day mortality, 99% freedom from cardiac death at 4 years,
88% freedom from aortic valve-related reoperation, and free-
dom from recurrent AR42 in 83% of the patients at 3 years.
No severe bleeding or thromboembolic events were reported
in the follow-up period. At this point we would like to
emphasize the extraordinarily high percentage of bicuspid
aortic valves in our group at 60%. Our results are in line, or at
least comparable to data published by others.
Very recently, El Khoury et al. reported their results of 475
patients who underwent elective aortic valve repair for aortic
regurgitation or aortic aneurysm over a 15 year period [21].
They found 95% and 85% freedom from cardiac death at 5 and
10 years. After adjustment for age, they found surprisingly that
the patients with a bicuspid aortic valve had superior survival
(hazard ratio [HR], 0.2; p¼0.010) than those with tricuspid one.
The freedom from aortic valve-related reoperation and free-
dom from signiﬁcant recurrent AR was 94% and 91% at 5 years
and 86% and 85% at 10 years, respectively. There was no
difference in freedom from signiﬁcant recurrent AR and in
aortic valve reoperation between bicuspid and tricuspid valves,
even after adjustment to age. The difference in survival, in
freedom of signiﬁcant recurrent AR and in aortic valve reo-
peration between repair with or without root replacement was
not investigated in this study. However, the percentage of
bicuspid aortic valve in their group was only 34%.
Schäfers et al. published results of 640 patients after aortic
valve repair over the period of 12 years [22]. The 30-day
mortality in their study cohort was 3.4% (22/640), which is
slightly higher than published in other series. The overall
survival was 92% at 5 years and 80% at 10 years with
signiﬁcantly better survival in patients with a bicuspid versus
a tricuspid aortic valve (p¼0.0004). The freedom from aortic
valve-related reoperation at 5 and 10 years was 88% and 81%
in bicuspid and 97% and 93% in tricuspid aortic valves
(p¼0.0013), respectively. A similar trend in freedom from
reoperation was shown between aortic valve repair with or
without root replacement in favor of root replacement
(p¼0.060). The freedom from recurrent ARZ2 at 5/10 years
was 86%/83% for bicuspid aortic valve and 87%/80% for
tricuspid aortic valve (p¼0.950). The freedom from ARZ2 at
5/10 years was signiﬁcantly better in patients having under-
gone root replacement (89%/84%) compared to aortic valve
repair isolated (83%/83%) (p¼0.025). Interestingly, the free-
dom from all valve-related complications (reoperation,
thromboembolism, endocarditis and hemorrhage) at 10 years
was only 88% with signiﬁcantly better results after tricuspid
versus bicuspid aortic valve repair (10 years: 93% vs. 80%;
p¼0.0017). But it is necessary to emphasis, that the vast
majority of these adverse events were reoperations since
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infective endocarditis are rarely seen in these operations. In
this patient population 205/640 patients had bicuspid aortic
valve (32%).
Some authors pointed out the inferior long-term results
after aortic root remodeling (Yacoub procedure) compared to
aortic valve reimplantation (David procedure) due to recur-
rent AR [23,24]. The reason for the failure is the dilation of
aortic annulus, which is not stabilized in case of aortic root
remodeling. However, in-vitro and in-vivo studies showed
the superiority of aortic root remodeling in terms of root
hemodynamics compared to the valve reimplantation [25,26],
even with the use of Valsalva prosthesis [27]. The under-
standing of importance of annular stabilization led some
cardiac surgeons to add an aortic valve annuloplasty to the
root remodeling to eliminate potential future annulus dila-
tion [15,20]. Having Lansac et al. introduced the external
aortic annuloplasty ring [16] the concept of a physiologic,
standardized aortic valve-sparing operation combining “the
more physiological” aortic root remodeling with the implan-
tation of Extra-Aortic annuloplasty expansible ring (Coronéo
Inc., Canada) was fully established (Fig. 6) [6]. This approach
was also adopted at our department 3 years ago and it has
become the procedure of choice in patients with AR and root
dilatation.5. Limitations of the study
There are several limitations of our study. It is not a
randomized comparison of patients. Although prospective
collection of data was performed, the evaluation was done
retrospectively. The study is based on a single-centerFig. 6 – Illustration depicting a standardized aortic valve-
sparing operation combining “the more physiological” aortic
root remodeling with the implantation of Extra-Aortic
annuloplasty expansible ring.experience with a new operative technique being implemen-
ted in the past 5 years. Additionally, different techniques of
AV repair and lack of some data in different periods of follow-
up may be confounding. Finally, the cohort of our patients is
relatively small and the follow-up period only mid-term.6. Conclusion
Short- and mid-term data analysis showed very acceptable
results, comparable even with larger published studies. We
think, therefore, aortic valve repair should be a part of the
contemporary cardio-surgical armamentarium, especially for
younger patients with an appropriate indication.
r e f e r e n c e s
[1] D.E. Harken, H.S. Soroff, W.J. Taylor, et al., Partial and
complete prostheses in aortic insufﬁciency, Journal of
Thoracic and Cardiovascular Surgery 40 (1960) 744–762.
[2] H. Bentall, A. De Bono, A technique for complete replacement
of the ascending aorta, Thorax 23 (1968) 338–339.
[3] M. Yacoub, A. Fagan, P. Stassano, et al., Result of valve
conserving operations for aortic regurgitation, Circulation
68 (1983) 321.
[4] T.E. David, C.M. Feindel, An aortic valve-sparing operation for
patients with aortic incompetence and aneurysm of the
ascending aorta, Journal of Thoracic and Cardiovascular
Surgery 103 (1992) 617–622.
[5] M. Boodhwani, L. de Kerchove, D. Glineur, et al., Repair-
oriented classiﬁcation of aortic insufﬁciency: impact on
surgical techniques and clinical outcomes, Journal of
Thoracic and Cardiovascular Surgery 137 (2009) 286–294.
[6] E. Lansac, I. Di Centa, G. Sleilaty, et al., An aortic ring: from
physiologic reconstruction of the root to a standardized
approach for aortic valve repair, Journal of Thoracic and
Cardiovascular Surgery 140 (2010) S28–35.
[7] D. Aicher, H.-J. Schäfers, Aortic valve repair – current status,
indications, and outcomes, Seminars in Thoracic and
Cardiovascular Surgery 24 (2012) 195–201.
[8] I.V. Volguina, D.C. Miller, S.A. LeMaire, et al., Valve-sparing
and valve-replacing techniques for aortic root replacement
in patients with Marfan syndrome: analysis of early
outcome, Journal of Thoracic and Cardiovascular Surgery 137
(2009) 1124–1132.
[9] P. Nataf, E. Lansac, Dilation of the thoracic aorta: medical and
surgical management, Heart 92 (2006) 1345–1352.
[10] P. Fila, J. Ondrasek, H. Bedanova, et al., Aortic valve sparing
operations versus composite graft implantation in acute
aortic dissections, Cor et Vasa 54 (2012) e137–e142.
[11] J. Vojacek, M. Tuna, S. Vanekova, et al., Aortic valve-sparing
surgery—early and mid-term outcomes, Cor et Vasa 51 (2009)
781–788.
[12] K. Pethig, A. Milz, C. Hagl, et al., Aortic valve reimplantation
in ascending aortic aneurysm: risk factors for early valve
failure, Annals of Thoracic Surgery 73 (2002) 29–33.
[13] H.-J. Schäfers, B. Bierbach, D. Aicher, A new approach to the
assessment of aortic cusp geometry, Journal of Thoracic and
Cardiovascular Surgery 132 (2006) 436–438.
[14] C. Cabrol, A. Cabrol, G. Guiraudon, et al., Le traitement de
l'insufﬁsance aortique par'annuloplastie aortique, Archives
des Maladies du Coeur et des Vaisseaux 59 (1966) 1305–1312.
[15] D. Aicher, U. Schneider, W. Schmied, et al., Early results with
annular support in reconstruction of the bicuspid aortic
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 7 9 – e 4 8 6e486valve, Journal of Thoracic and Cardiovascular Surgery 145
(2013) S30–34.
[16] E. Lansac, I. Di Centa, M.D., S. Varnous, et al., External aortic
annuloplasty ring for valve-sparing procedures, Annals of
Thoracic Surgery 79 (2005) 356–358.
[17] C.W. Akins, D.C. Miller, M.I. Turina, et al., Guidelines for
reporting mortality and morbidity after cardiac valve
interventions, Journal of Thoracic and Cardiovascular
Surgery 135 (2008) 732–738.
[18] E.M. Lee, L.M. Shapiro, F.C. Wells, et al., Superiority of mitral
valve repair in surgery for degenerative mitral regurgitation,
European Heart Journal 18 (1997) 655–663.
[19] M. Boodhwani, L. de Kerchove, D. Glineur, et al., Repair of
regurgitant bicuspid aortic valves: a systematic approach,
Journal of Thoracic and Cardiovascular Surgery 140 (2010)
276–284.
[20] E. Lansac, I. Di Centa, N. Bonnet N, et al., Aortic prosthetic
ring annuloplasty: a useful adjunct to a standardized aortic
valve-sparing procedure?, European Journal of Cardio-
Thoracic Surgery 29 (2006) 537–544.
[21] J. Price, L. De Kerchove, D. Glineur, et al., Risk of valve-related
events after aortic valve repair, Annals of Thoracic Surgery
95 (2013) 606–612.[22] D. Aicher, R. Fries, S. Rodionycheva, et al., Aortic valve repair
leads to a low incidence of valve-related complications,
European Journal of Cardio-Thoracic Surgery 37 (2010)
127–132.
[23] T.E. David, C.M. Feindel, G.D. Webb, et al., Long-term results
of aortic valve-sparing operations for aortic root aneurysm,
Journal of Thoracic and Cardiovascular Surgery 132 (2006)
347–354.
[24] A.W. Erasmi, H.H. Sievers, J.F. Bechtel, et al., Remodeling or
reimplantation for valve-sparing aortic root surgery?, Annals
of Thoracic Surgery 83 (2007) S752–756.
[25] R. Fries, T. Graeter, D. Aicher, et al., In vitro comparison of
aortic valve movement after valve-preserving aortic
replacement, Journal of Thoracic and Cardiovascular Surgery
132 (2006) 32–37.
[26] R.G. Leyh, C. Schmidtke, H.-H. Sievers, et al., Opening and
closing characteristics of the aortic valve after different types
of valve-preserving surgery, Circulation 100 (1999) 2153–2160.
[27] R. De Paulis, G.M. De Matteis, P. Nardi, et al., Analysis of valve
motion after the reimplantation type of valve-sparing
procedure (David I) with a new aortic root conduit, Annals of
Thoracic Surgery 74 (2002) 53–57.
